Pradhan Mantri Bhartiya Janaushadhi Pariyojana
Category: Business & Entrepreneurship, Health & Wellness, Skills & Employment, Social welfare & Empowerment
Level: Central | State: All
Ministry: Ministry Of Chemicals And Fertilizers

Details:
The scheme "Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)" was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, in November 2008. The branded (Generic) medicines are sold at significantly higher prices than their un-branded generic equivalents, though are identical in therapeutic value. Given the widespread poverty across the country, making available reasonably priced quality generic medicines in the market would benefit everyone.
**Objectives:**
To make quality generic medicines available at affordable prices to all, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India in November 2008. Under the scheme, dedicated outlets known as Janaushadhi Kendras are opened to provide generic medicines at affordable prices. As of 30.11.2023, 10,000 Janaushadhi Kendras are functional nationwide. The product basket of PMBJP comprises 1965 drugs and 293 surgical items. The scheme is implemented by a society registered under the Societies Registration Act, viz., Pharma & Medical Bureau of India (PMBI), [erstwhile Bureau of Pharma PSUs of India (BPPI)].

1. Ensure access to quality medicines for all sections of the population, especially the poor and the deprived ones.
1. Create awareness about generic medicines through education and publicity to counter the perception that quality is synonymous with high prices only.
1. Generate employment by engaging individual entrepreneurs in the opening of the PMBJP Kendra.

Benefits:
The scheme is operated by government agencies as well as by private entrepreneurs.
1. 
Normal Incentive:
 The incentive provided to the Kendra owners has been enhanced from the existing ₹ 2,50,000/- to up to ₹ 5,00,000/- to be given @ 15% of monthly purchases made, subject to a ceiling of ₹ 15,000/- per month.
2. 
Special Incentive: 
A one-time incentive of ₹ 2,00,000/- (in addition to normal incentives) is to be provided for furniture & fixtures and computers & printers to the PMBJP Kendras opened in the North-Eastern States, Himalayan areas, Island territories, and backward areas mentioned as an aspirational district by NITI Aayog or opened by women entrepreneurs, Divyang, SCs& STs.
3. The prices of Janaushadhi medicines are 50%–90% less than those of branded medicines in the open market.
4. Medicines are procured only from World Health Organization-Good Manufacturing Practices (WHO-GMP)-certified suppliers to ensure the quality of the products.
5. Each batch of the drug is tested at laboratories accredited by the ‘National Accreditation Board for Testing and Calibration Laboratories (NABL) to ensure the best quality.
6. The operating agency will be provided a 20% margin on the MRP (excluding taxes) of each drug.

Janaushadhi Suvidha Sanitary Napkin
As an important step in ensuring the health security for Indian women, Janaushadhi Suvidha Oxo-biodegradable Sanitary Napkins were launched on 27.08.2019 to be made available at Re.1/- per pad only. Janaushadhi Suvidha Napkins are being made available for sale in more than 10,000 PMBJP Kendras across the country. The cumulative sales of Suvidha Napkins as on 30.11.2023 is 47.87 crores.

Eligibility Criteria:
1. Individual applicants must have a D. Pharma/B. Pharma degree, or he/she has to employ D. Pharma/B. Pharma degree holders and produce proof of the same at the time of submitting applications or at the time of final approval.
1. Any organization or NGO applying for a PMBJK will have to employ B. Pharma / D. Pharma degree holders and produce proof of the same at the time of submitting applications or at the time of final approval. 
1. In government hospital premises, including medical colleges, the preferred agencies would be reputed NGOs/Charitable organizations, but individuals would also be eligible.